After attracting $3.7 billion in new capital and minting young billionaires at Polymarket and Kalshi, prediction market startups are all the rage, especially for…
AI CEOs are openly trash-talking each other, sniping over advertising and their philosophical approaches to the future.Why it matters: The squabbling is intensifying as…
He made pledges to Sen. Cassidy, then overhauled ACIP, changed vaccine schedules, website wordingAs Robert F. Kennedy Jr. made a series of promises to…
See the totals from NIH, FDA, CDC, and CMS, tooSince Robert F. Kennedy Jr. took the helm of HHS last February, his department has…
As behavioral health crises drive prolonged emergency department boarding and staff burnout, health systems are adopting targeted strategies to ease the burden and improve…
The same financial pressures hospitals are facing are increasingly evident at the physician enterprise level, according to Kaufman Hall’s latest quarterly “Physician Flash Report,”…
CMS unveiled a proposed rule Feb. 9 that would reshape the ACA marketplace for plan year 2027, expanding insurer flexibility on plan design, tightening…
Individuals with strong attention-deficit/hyperactivity disorder (ADHD) symptoms, related to inefficient cognitive executive function, may experience a surprising benefit: a natural inclination toward a type…
From Optum launching a pair of prior authorization tools to UnitedHealthcare projecting it will lose up to 2.8 million members in 2026, here are…
Orna Therapeutics brings Eli Lilly an in vivo cell therapy ready for Phase 1 testing as a potential treatment for autoimmune diseases. Lilly is…